AzTrials
AzTrials

Anxiety DisordersNCT01533402

Internet-delivered Cognitive Behavior Therapy (CBT) for Children Age 8-12 Years With Anxiety Disorders

A study testing therapist support and Internet-delivered CBT in people with Anxiety Disorders, run by Karolinska Institutet at 1 site in Sweden.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to investigate whether a 10 week Internet-delivered CBT is a feasible approach to treat children (age 8-12 years) with anxiety disorder (social phobia, panic disorder, specific phobia, generalized anxiety disorder or separation anxiety disorder). Read more about this study

Who is it for?
Ages 8 to 12 years
Conditions the study is for
Anxiety Disorders
What is being tested?
therapist support and Internet-delivered CBT
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
128 participants
Where
1 siteSweden
Study dates
Feb 2012to Apr 2014
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 8 to 12 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • primary diagnosis of social phobia, panic disorder, specific phobia, generalized anxiety disorder or separation anxiety disorder,
  • age between 8 and 12 years,
  • ability to read and write Swedish and
  • with access to a computer and use of internet.

Who cannot join

  • Presence of neuropsychiatric diagnosis or a primary psychiatric disorder other than those that the treatment aims at.

Trial locations and contacts

1 site in 1 country.

Sweden1 site
  • Barn-och ungdomspsykiatrin, Stockholm

    Stockholm, 118 91

Other trials in Sweden

About this study

Official title: Internet-delivered Cognitive Behavior Therapy (CBT) Treatment for Anxiety Disorders in Children Age 8-12 Years - a Randomised Controlled Trial

The purpose of this study is to investigate whether a 10 week Internet-delivered CBT is a feasible approach to treat children (age 8-12 years) with anxiety disorder (social phobia, panic disorder, specific phobia, generalized anxiety disorder or separation anxiety disorder). The program is directed toward both the parents and children. The patients work with the treatment is supported through on-line contact with a therapist. Approximately 128 patients will be included in the study and randomized to either condition. All included patients are assessed before the treatment starts and after 10 weeks (post treatment). Follow-up assessments are conducted at 3 and 12 months after treatment.

Being tested
therapist support, Internet-delivered CBT
Keywords
Cognitive behavior therapy, Internet, Anxiety disorders, Children
Medical subject headings
Anxiety Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • therapist supportBehavioural

    Weekly therapist support without CBT-interventions

  • Internet-delivered CBTBehavioural

    Internet-delivered cognitive behavioural therapy with therapist support

Study groups in NCT01533402
Study groupRoleWhat they receive
Attention controlPlacebo comparatorWeekly support from therapist without CBT-interventions
Receives: Behavioral: therapist support
Internet CBTExperimentalInternet-delivered cognitive behavioural therapy with therapy support
Receives: Behavioral: Internet-delivered CBT

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Anxiety symptoms

    Change from baseline in anxiety symptoms. Clinician Severity Rating (CSR) assessed by a clinician with Anxiety Diagnostic Interview Schedule (ADIS C/P).

    Measured: two - three weeks pre treatment and 10 weeks, 3 months and 12 months post treatment

Secondary outcomes (11)
  1. Anxiety symptoms

    Change from baseline in anxiety symptoms. Fear Survey Schedule for Children (FSSC-C/P).

    Measured: two weeks pre treatment and 10 weeks, 3 months and 12 months post treatment

  2. Quality of Life

    Quality of Life (QOLI)

    Measured: two weeks pre treatment and 10 weeks, 3 months and 12 months post treatment

  3. comorbidity

    Development and Wellbeing Assessment (DAWBA)

    Measured: two - four weeks before treatment starts

  4. Depressive symptoms

    Children Depression Scale (CDI)

    Measured: two weeks pre treatment and 10 weeks, 3 months and 12 months post treatment

  5. Funtional impairment

    Children´s Global Assessment Scale (CGAS)

    Measured: two weeks pre treatment and 10 weeks, 3 months and 12 months post treatment

  6. Client Satisfaction Scale

    Client Satisfaction Scale (CSS)

    Measured: two weeks before treatment and 10 weeks, 3 and 12 months post treatment

  7. Parental psychopathology

    Primary Care Evaluation of Mental disorders (Prime-MD)

    Measured: two weeks pre treatment

  8. Anxiety symptoms

    Change from baseline in anxiety symptoms. Penn State Worry Questionnaire for Children (PSWQ-C).

    Measured: two weeks pre treatment and 10 weeks, 3 months and 12 months post treatment

  9. Anxiety symptoms

    Change from baseline in anxiety symptoms. Separation Anxiety Inventory for Children (SAI-C/P)

    Measured: two weeks pre treatment and 10 weeks, 3 months and 12 months post treatment

  10. Anxiety symptoms

    Change from baseline in anxiety symptoms. Social Phobia and Anxiety Inventory (SPAI-C/P)

    Measured: two weeks pre treatment and 10 weeks, 3 months and 12 months post treatment

  11. Anxiety symptoms

    Change from baseline in anxiety symptoms. Spence Child Anxiety Scale C/P (SCAS-C/P).

    Measured: two weeks pre treatment and 10 weeks, 3 months and 12 months post treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Feb 2012 (estimated)
  2. Study startFeb 2012
  3. Primary completionDec 2013
  4. Study completionApr 2014

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
128 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01533402
Sponsor's protocol ID
2011/2027-31/5
Status last verified
Sep 2014
First submitted
6 Feb 2012
Last updated
9 Sep 2014
Results posted
No
Data monitoring committee
No

Publications

  • Vigerland S, Serlachius E, Thulin U, Andersson G, Larsson JO, Ljotsson B. Long-term outcomes and predictors of internet-delivered cognitive behavioral therapy for childhood anxiety disorders. Behav Res Ther. 2017 Mar;90:67-75. doi: 10.1016/j.brat.2016.12.008. Epub 2016 Dec 14.

    PubMed 28012300
  • Vigerland S, Ljotsson B, Thulin U, Ost LG, Andersson G, Serlachius E. Internet-delivered cognitive behavioural therapy for children with anxiety disorders: A randomised controlled trial. Behav Res Ther. 2016 Jan;76:47-56. doi: 10.1016/j.brat.2015.11.006. Epub 2015 Nov 19.

    PubMed 26649465

Questions about this trial

What is this clinical trial studying?

A study testing therapist support and Internet-delivered CBT in people with Anxiety Disorders, run by Karolinska Institutet at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Sep 2014. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Anxiety symptoms (time frame: two - three weeks pre treatment and 10 weeks, 3 months and 12 months post treatment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01533402, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Sep 2014.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in